Jeffrey B. Mirviss, EVP&Pres, Periph Intervent at BOSTON SCIENTIFIC CORP (BSX), sold 11,080 shares at $46.75 ($518K) on 2022-12-12, disclosed to the SEC on 2022-12-13.
Seasonal sale ($518k) by EVP&Pres, Periph Intervent — this insider has traded BSX in December in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| BSX | SELL | 2025-02-13 | $2.7M | — | Filing → |
| BSX | SELL | 2025-01-03 | $1.3M | — | Filing → |
| BSX | SELL | 2024-05-30 | $9.6M | — | Filing → |